| CI-FEE6BE |
L-Serine, 2-Methyl-, Methyl ester, hydrochloride |
114396-63-3 |
C5H12ClNO3 |
169.6067 |
|
| CI-FEE698 |
L-Proline, 3-hydroxy-5-methyl-, (3R,5R)- (9CI) |
114717-06-5 |
|
|
MFCD19219079 |
| CI-FEE697 |
L-Proline, 3-hydroxy-5-methyl-, (2alpha,3alpha,5alpha)- (9CI) |
114717-05-4 |
|
|
MFCD19221299 |
| CI-FEE696 |
L-Proline, 3-hydroxy-5-methyl-, (2alpha,3beta,5beta)- (9CI) |
114717-04-3 |
|
|
MFCD19219080 |
| CI-FEE667 |
LHRH, Phe(5)-delta-Ala(6)-N-Et-ProNH2(9)- |
114681-52-6 |
|
|
|
| CI-FEE666 |
LHRH, Phe(5)-delta-Ala(6)- |
114681-51-5 |
|
|
|
| CI-FEE665 |
L-Proline, 3-hydroxy-5-methyl-, methyl ester, (2alpha,3beta,5alpha)- (9CI) |
114681-13-9 |
|
|
MFCD28956715 |
| CI-FEE5B7 |
L-Proline, 1-(2-propenyl)-, 2-propenyl ester |
114812-37-2 |
|
|
|
| CI-FEE5A5 |
Losartan IMpurity C (Isolosartan) |
114799-13-2 |
C22H23ClN6O |
422.9106 |
MFCD27967019 |
| CI-FEE5A4 |
Losartan Carboxaldehyde |
114798-36-6 |
C22H21ClN6O |
420.8947 |
MFCD00870256 |
| CI-FEE5A3 |
Losartan |
114798-26-4 |
C22H23ClN6O |
422.9106 |
MFCD00865831 |
| CI-FEE54D |
L-LEUCINE THIOAMIDE HYDROCHLORIDE |
114747-12-5 |
|
|
MFCD09752925 |
| CI-FEE51E |
L-Proline, 3-hydroxy-5-methyl-, methyl ester, (2alpha,3beta,5beta)- (9CI) |
114718-40-0 |
|
|
MFCD30063947 |
| CI-FEE4BC |
L-Proline, 3-hydroxy-5-methyl-, (3S,5S)- (9CI) |
114882-73-4 |
|
|
MFCD19218180 |
| CI-FEE44D |
L-α-Methyl DOPA Methyl Ester Hydrochloride |
115054-62-1 |
|
|
MFCD19105335 |
| CI-FEE3D5 |
Levulinohydroxamic acid (6CI) |
114983-43-6 |
|
|
|
| CI-FEE39F |
L-glycero-L-galacto-Heptitol, 2,6-anhydro-, pentaacetate |
115224-88-9 |
|
|
|
| CI-FEE395 |
lentinellic acid |
115219-90-4 |
|
|
|
| CI-FEE36E |
2-(L-RHAMNO-TETRAHYDROXYPENTYL)-4(R)-1,3-THIAZOLIDINE-4-CARBOXYLIC ACID |
115184-32-2 |
C9H17NO6S |
267.2994 |
MFCD08704184 |
| CI-FEE36D |
2-(L-XYLO-TETRAHYDROXYBUTYL)-4(R)-1,3-THIAZOLIDINE-4-CARBOXYLIC ACID |
115184-30-0 |
C8H15NO6S |
253.2728 |
MFCD08703975 |
